Galia Benchaya

Fourth-year PharmD candidate (Class of 2026) with a B.Sc. in Pharmacology and Toxicology, recognized for leadership and a strong commitment to advancing oncology care through Global Medical Affairs. Expertise includes evidence-based pharmacotherapy, interdisciplinary collaboration, and scientific communication, enhanced by a unique global perspective from diverse healthcare settings and fluency in multiple languages. Proficient in integrating clinical insights with strategic pharmaceutical initiatives to drive optimized patient outcomes. Dedicated to leveraging knowledge and experience for impactful contributions in the field of oncology.

• NYS Pharmacy Intern Permit | 2023-05
• CPR & BLS, National Safety Council | Active 2025–2027
• APhA Pharmacy-Based Immunization Delivery | 2023–Present
• Narcan Administration & Overdose Prevention | 2022-12
• Pharmacy Technology & Automation Certificate | 2025-04

Advanced Pharmacy Practice Experience (APPE)
NYP Brooklyn Methodist – Oncology Clinical Rotation | Sep 2025 – Oct 2025

• Will manage and evaluate chemotherapy regimens, supportive care medications, and targeted therapy protocols.
• Will apply clinical judgment in dose adjustments, adverse event monitoring, and patient counseling.

Upcoming APPE Rotations (2025–2026)
Block 5: Institutional APPE | 10/13/25 – 11/17/25
Brookdale University Hospital Medical Center – Preceptor: Dr. Maria Claudio-Saez

• Will provide comprehensive institutional pharmacy services, including inpatient medication management and clinical decision-making.

Block 6: Elective Acute Care APPE | 11/19/25 – 01/05/26
New York Presbyterian – Columbia University Irving Medical Center – Preceptor: Dr. Densley Perez

• Will gain acute care experience in managing complex patient cases, medication therapy monitoring, and interdisciplinary collaboration.

Block 7: General Inpatient Medicine APPE | 01/21/26 – 02/25/26
New York Presbyterian – Columbia University Irving Medical Center – Preceptor: Dr. Xinyi Huang (Xena)

• Will conduct comprehensive patient care, including pharmacotherapy evaluation, order verification, and clinical counseling in inpatient settings.

Block 8: Elective – Medication Therapy Management (Remote) | 02/27/26 – 04/03/26
Preventel Health – Preceptor: Dr. Valerie Lam Van

• Will execute remote medication therapy management, including patient counseling, adherence monitoring, and therapeutic optimization.

Block 9: Community APPE | 04/06/26 – 05/08/26
CVS Pharmacy #04182, Surfside, FL – Preceptor: Dr. Lara Guigui

• Will deliver community pharmacy services, patient education, immunizations, and chronic disease management.

Introductory Pharmacy Practice Experience (IPPE) 

NYP Columbia Hospital — APPE Pharmacy Experience
August 2024

• Shadowed decentralized pharmacists and technicians across hospital satellite pharmacies, gaining exposure to oncology therapeutics and clinical decision-making.
• Filled Patient-Specific Medications (PSM) in Omnicell and managed critical low inventory with precision and efficiency.
• Delivered patient-centered counseling, reinforcing adherence and safety in complex treatment regimens.
• Assisted with sterile compounding, IV preparation, and OR tray management, maintaining strict attention to detail.
• Collaborated with interdisciplinary teams to optimize medication distribution and ensure continuity of care.

Joseph’s Pharmacy — Introductory Pharmacy Practice Experience (IPPE)
July 2023

• Managed prescription processing, prior authorizations, and formulary coordination, ensuring patient safety and treatment continuity.
• Monitored adherence and outcomes, providing patient-focused interventions to enhance therapeutic success.
• Compounded sterile and non-sterile formulations with meticulous attention to protocol and quality.
• Developed strong rapport with patients and prescribers, fostering trust and promoting informed decision-making.

• - Benchaya G, Hanna E, Huang M, Sadova Y, Zerilli T. Neuriva: A Closer Look at the Efficacy and Safety of This Popular Supplement. Pharmacy Times. Published online July 17, 2025. Link
• - Poster: The Role of Akkermansia Muciniphila in Gut Health, Metabolic Function, and Inflammation Authors: Galia Benchaya, BPS, PharmD Candidate of 2026; Enjoi Hana, BPS, MS, PharmD Candidate of 2026 Research Coordinator: Jadwiga S. Najib, BS, PharmD To be presented at Midyear, December 2025, Las Vegas, Nevada
• - Journal Club Presentation: Nivolumab + AVD: Assessing Its Efficacy and Safety at Treating Advanced-Stage Classic Hodgkin’s Lymphoma | 2025-09 Author: Galia Benchaya, BPS, PharmD Candidate of 2026 Research Coordinator: Dr. Yuri Kim, PharmD, BCOP
• - Formal Patient Case Presentation: Diffuse Large B-Cell Lymphoma Treated with R-CHP + Polatuzumab | 2025-09 Author: Galia Benchaya, BPS, PharmD Candidate of 2026 Research Coordinator: Dr. Yuri Kim, PharmD, BCOP
• - Formal Patient Case Presentation: Acute Promyelocytic Leukemia (APL) Treated with Arsenic Trioxide + ATRA | 2025-09 Author: Galia Benchaya, BPS, PharmD Candidate of 2026 Research Coordinator: Dr. Yuri Kim, PharmD, BCOP
• - Research Study: Nipocalimab: A Study Assessing Its Safety and Efficacy to Treat Severe Hemolytic Disease of The Fetus and Newborn (HDFN) | 2024-07 Author: Galia Benchaya, BPS, PharmD Candidate of 2026 Research Coordinator: Dr. Peter Campbell, PharmD, MBA, BCOP